Registrar Corp (CMC Medical Devices) shows up when manufacturers search for a Latin American registration holder or sanitary-registration partner. This article uses only what Registrar Corp (CMC Medical Devices) publishes on its own site (www.registrarcorp.com/medical-devices/global-representation · www.registrarcorp.com/contact/mexico-office), then compares it with the multi-country subscription from bioaccess®. It is a practitioner comparison, not a teardown.
What Registrar Corp (CMC Medical Devices) publishes
Registrar Corp is a long-standing U.S. FDA-compliance firm that works with CMC Medical Devices on global representation. Its representation page lists Europe, the UK, Switzerland, Australia, China, the US, India, Korea, Southeast Asia and "South America." We found no country pages naming ANVISA, COFEPRIS, INVIMA or ANMAT holder services. Registrar Corp does publish a Mexico office contact page.
Registrar Corp (CMC Medical Devices) vs bioaccess®
| Dimension | Registrar Corp (CMC Medical Devices) | bioaccess® |
|---|---|---|
| Public product | Global authorized-representative network; Latin America described as "South America" | LATAM Launch Subscription: registration, in-country holder, certified translations, government fees, tecnovigilancia (import shipments quoted separately) |
| Geography | "South America" (no Latin American regulator named on the page) | 19 LATAM markets |
| Public pricing | None published for Latin America | USD 7,500 per year per country for the first device family |
| Holder vs distributor | See the provider’s own terms | Holds through its own in-country entities, with defined transfer provisions; the registration is never leverage |
| Bridge from a clinical trial | None published | Trial-to-Market Bridge: 20% off for bioaccess® clinical-trial clients |
Where each one fits
If you need one vendor for US Agent, EU, UK, Swiss and Asian representation and Latin America is a later thought, Registrar Corp is a reasonable global bundle.
The LATAM Launch Subscription from bioaccess® is a different product. bioaccess® registers already FDA-cleared or CE-marked devices and holds them through its own in-country entities across 19 Latin American markets, including COFEPRIS, ANVISA, INVIMA, ANMAT, ISP and DIGEMID. The published card is USD 7,500 per year per country for the first device family, with government submission fees, certified or sworn translations, the in-country titular or holder, and tecnovigilancia inside the fee (importer-of-record shipments are priced separately on the hub). Multi-country discounts are 10% at three or more countries and 15% at five or more. The registration is held for the manufacturer’s benefit, with defined transfer provisions if you ever change partners or set up your own entity.
One country and one local partner is enough? Hire the firm that publishes that job. Several LATAM labels under one holder who is not your distributor? Start at bioaccess® market access, read the LATAM importer of record guide, try the LATAM Launch Calculator, or request a registration quote.
Competitor facts from the Registrar Corp (CMC Medical Devices) public pages linked above, reviewed for bioaccess® competitive research (Aug–Oct 2026). Claims are theirs. No invented clients, prices or contacts.
Leave a Reply